Summary
Two subtypes of thrombospondin (TSP-1 and TSP-2) have inhibitory roles in angiogenesis in vitro, although the biological significance of these TSP isoforms has not been determined in vivo. We examined TSP-1 and TSP-2 gene expression by reverse transcription polymerase chain reaction (RT-PCR) analysis in 61 colon cancers. Thirty-eight of these 61 colon cancers were positive for TSP-2 expression and showed hepatic metastasis at a significantly lower incidence than those without TSP-2 expression (P = 0.02). TSP-2 expression was significantly associated with M0 stage in these colon cancers (P = 0.03), whereas TSP-1 expression showed no apparent correlation with these factors. The colon cancer patients with TSP-2 expression showed a significantly low frequency of liver metastasis correlated with the cell-associated isoform of vascular endothelial growth factor (VEGF-189) (P = 0.0006). Vascularity was estimated by CD34 staining, and TSP-2(–)/VEGF-189(+) colon cancers showed significantly increased vessel counts and density in the stroma (P < 0.0001). TSP-2(–)/VEGF-189(+) colon cancer patients also showed significantly poorer prognosis compared with those with TSP-2(+) / VEGF-189(–) (P = 0.0014). These results suggest that colon cancer metastasis is critically determined by angiogenesis resulting from the balance between the angioinhibitory factor TSP-2 and angiogenic factor VEGF-189.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Baenziger, N. L., Brodie, G. N. & Majerus, P. W. (1972). Isolation and properties of a thrombin sensitive protein of human platelets. J Biol Chem 247: 2723–2731.
Bertin, N., Clezardin, P., Kubiak, R. & Frappart, L. (1997). Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Res 57: 396–399.
Bornstein, P. (1992). Thrombospondins: structure and regulation of expression. FASEB J 6: 3290–3299.
Bornstein, P., O’Rourke, K., Wikstrom, K., Wolf, F. W., Katz, R., Li, P. & Dixit, V. M. (1991). A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem 266: 12821–12824.
Clezardin, P., Frappart, L., Clerget, M., Pechoux, C. & Delmas, P. D. (1993). Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res 53: 1421–1430.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M. & Feder, J. (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470–1478.
Gehron, R. P., Young, M. F., Fisher, L. W. & McClain, T. D. (1989). Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix. J Cell Biol 108: 719–727.
Graham, C., Rivers, J., Kerbel, R., Stankiewicz, K. & White, W. (1994). Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. Am J Pathol 145: 510–514.
Grossfeld, G. D., Shi, S. R., Ginsberg, D. A., Rich, K. A., Skinner, D. G., Taylor, C. R. & Cote, R. J. (1996). Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 44: 761–766.
Grossfeld, G. D., Ginsberg, D. A., Stein, J. P., Bochner, B. H., Esrig, D., Groshen, S., Dunn, M., Nichols, P. W., Taylor, C. R., Skinner, D. G. & Cote, R. J. (1997). Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89: 219–227.
Hsu, S. C., Volpert, O. V., Steck, P. A., Mikkelsen, T., Poverini, P. J., Rao, S., Chou, P. & Bouck, N. (1996). Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56: 5684–5691.
Iruela-Arispe, M. L., Bornstein, P. & Sage, H. (1991). Thrombospondin exerts an anti-angiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88: 5026–5030.
Jaffe, E. A., Ruggiero, J. T., Leung, L. L. K., Doyle, M. J., McKeon-Longo, P. J. & Mosher, D. F. (1983). Cultured human fibloblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 80: 998–1002.
Jaffe, E. A., Ruggiero, J. T. & Falcon, D. J. (1985). Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65: 79–84.
Labell, T. L. & Byers, P. H. (1993). Sequence and characterization of the complete human thrombospondin-2 cDNA: potential regulatory role for the 3′ untranslated region. Genomics 17: 225–229.
Laherty, C. D., O’Rourke, K., Wolf, F. W., Katz, R., Seldin, M. F. & Dixit, V. M. (1992). Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. J Biol Chem 267: 3274–3281.
Laiho, M., Ronnstrand, L., Heino, J., Decaprio, J. A., Ludlow, J. W., Livingston, D. M. & Massague, J. (1991). Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40T antigen-sensitive growth-sensitive growth-inhibitory events. Mol Cell Biol 11: 972–978.
Lawler, J. (1986). The structural and functional properties of thrombospondin. Blood 67: 112–123.
Lawler, J., Duquette, M., Whittaker, C. A., Adams, J. C., McHenry, K. & Desimone, D. W. (1993). Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol 120: 1059–1067.
Legrand, C., Thibert, V., Dubernard, V., Begault, B. & Lawler, J. (1992). Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation. Blood 79: 1995–2003.
Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F. & Angeletti, C. A. (1992). Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340: 145–146.
Maeda, K., Chung, Y. S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., Arimoto, Y., Kondo, M. & Sawa, M. (1995). Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13: 477–481.
Majack, R. A., Mildbrandt, J. & Dixit, V. M. (1987). Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Biol Chem 262: 8821–8825.
Oldberg, A., Antonsson, P., Lindblom, K. & Heinegard, D. (1992). COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 267: 22346–22350.
O’Shea, K. S. & Dixit, V. M. (1988). Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 107: 2737–2748.
O’Shea, K. S., Liu, L. H. J., Kinnunen, L. H. & Dixit, V. M. (1990). Role of the extracellular matrix protein thrombospondin in the early development of the mouse embryo. J Cell Biol 111: 2713–2723.
Panetti, T. S., Chen, H., Misenheimer, T. M., Getzler, S. B. & Mosher, D. F. (1997). Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 129: 208–216.
Qian, X. & Tuszynski, G. P. (1996). Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med 212: 199–207.
Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasaws, S., Sasazuki, T. & Kerbel, R. S. (1995). Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55: 4575–4580.
Roberts, D. D., Sherwood, J. A. & Ginsburg, V. (1987). Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol 104: 131–139.
Sage, E. H. & Bornstein, P. (1991). Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 266: 14831–14834.
Stellmach, V., Volpert, O. V., Crawford, S. E., Lawler, J., Hynes, R. O. & Bouck, N. (1996). Tumour suppresser genes and angiogenesis. Eur J Cancer 32A: 2394–2400.
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, R. K. & Ellis, L. M. (1995). Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964–3968.
Takahashi, Y., Tucker, S. L., Kitadai, Y., Koura, A. N., Bucana, C. D., Cleary, K. R. & Ellis, L. M. (1997). Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132: 541–546.
Taraboletti, G., Roberts, D. D. & Liotta, L. A. (1987). Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 105: 2409–2415.
Tokunaga, T., Oshika, Y., Abe, Y., Ozeki, Y., Sadahiro, S., Kijima, H., Tsuchida, T., Yamazaki, H., Ueyama, Y., Tamaoki, N. & Nakamura, M. (1998). Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 996–1002.
Volpert, O. V., Tolsma, S. S., Pellerin, S., Feige, J. J., Chen, H., Mosher, D. F. & Bouck, N. (1995). Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217: 326–332.
Volpert, O. V., Dameron, K. M. & Bouck, N. (1997). Sequential development of an angiogenic phenotype by human fibloblasts progressing to tumorgenicity. Oncogene 14: 1495–1502.
Vos, H. L., Devarayalu, S., De Vries, Y. & Bornstein, P. (1992). Thrombospondin 3 (Thbs3), a new member of the thrombospondin family. J Biol Chem 267: 12192–12196.
Warren, S. R., Yuan, H., Matli, R. M., Gillett, A. N. & Ferrara, N. (1995). Regulation by vascular endothelial growth factor of human colon cancer tumorgenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789–1797.
Weidner, N., Semple, J. P., Welch, W. R. & Folkman, J. (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1–8.
Weidner, N., Carro, P. R., Flax, J., Blumenfeld, W. & Folkman, J. (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401–409.
Weinstat-Saalow, D. L., Zabrenetzky, V. S., Vanhoutte, K., Frazier, W. A., Roberts, D. D. & Steeg, P. S. (1994). Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54: 6504–6511.
Wight, T. N., Raugi, G. J., Mumby, S. M. & Bornstein, P. (1985). Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem 33: 295–295.
Zabrenetzky, V., Harris, C. C., Steeg, P. S. & Roberts, D. D. (1994). Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines. Int J Cancer 59: 191–195.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tokunaga, T., Nakamura, M., Oshika, Y. et al. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br J Cancer 79, 354–359 (1999). https://doi.org/10.1038/sj.bjc.6690056
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690056
Keywords
This article is cited by
-
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)
Angiogenesis (2019)
-
miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma
Oncogene (2016)
-
SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases
Clinical and Translational Oncology (2015)
-
DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer
BMC Cancer (2015)
-
Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer
Molecular Cancer (2014)